Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) NASDAQ: CPHR's share price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$12.49 and traded as high as C$12.60. Cipher Pharmaceuticals shares last traded at C$12.42, with a volume of 26,289 shares traded.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group set a C$12.50 price target on Cipher Pharmaceuticals and gave the stock a "hold" rating in a research note on Monday, April 7th.
Get Our Latest Report on Cipher Pharmaceuticals
Cipher Pharmaceuticals Price Performance
The firm has a market capitalization of C$223.34 million, a PE ratio of 13.74 and a beta of 1.20. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. The firm has a 50-day simple moving average of C$12.47 and a 200-day simple moving average of C$13.25.
Insider Activity at Cipher Pharmaceuticals
In other news, Director Harold Morton Wolkin sold 3,500 shares of the firm's stock in a transaction on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total value of C$47,215.00. 42.00% of the stock is currently owned by insiders.
Cipher Pharmaceuticals Company Profile
(
Get Free Report)
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.
See Also
Before you consider Cipher Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cipher Pharmaceuticals wasn't on the list.
While Cipher Pharmaceuticals currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
